These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35392890)

  • 1. Development and usability of a web-based patient-tailored tool to support adherence to urate-lowering therapy in gout.
    Te Kampe R; Boonen A; Jansen TL; Elling JM; Flendrie M; van Eijk-Hustings Y; Janssen M; van Durme C; de Vries H
    BMC Med Inform Decis Mak; 2022 Apr; 22(1):95. PubMed ID: 35392890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients.
    Te Kampe R; Boonen A; Jansen T; Janssen M; de Vries H; van Durme C
    RMD Open; 2022 Feb; 8(1):. PubMed ID: 35185008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout.
    Richardson JC; Liddle J; Mallen CD; Roddy E; Hider S; Prinjha S; Ziebland S
    BMC Musculoskelet Disord; 2016 Jun; 17():249. PubMed ID: 27267878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study.
    Singh JA
    Arthritis Res Ther; 2014 Mar; 16(2):R82. PubMed ID: 24678765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol.
    Day RO; Frensham LJ; Nguyen AD; Baysari MT; Aung E; Lau AYS; Zwar N; Reath J; Laba T; Li L; McLachlan A; Runciman WB; Buchbinder R; Clay-Williams R; Coiera E; Braithwaite J; McNeil HP; Hunter DJ; Pile KD; Portek I; WIlliams KM; Westbrook JI
    BMJ Open; 2017 Oct; 7(10):e017281. PubMed ID: 29042386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical efficacy of urate-lowering therapy in acute gout: a meta-analysis of randomized controlled trials.
    Zhang X; Tang Y; Wang M; Wang D; Li Q
    Clin Rheumatol; 2021 Feb; 40(2):701-710. PubMed ID: 32562072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rate of adherence to urate-lowering therapy and associated factors in Chinese gout patients: a cross-sectional study.
    Yin R; Cao H; Fu T; Zhang Q; Zhang L; Li L; Gu Z
    Rheumatol Int; 2017 Jul; 37(7):1187-1194. PubMed ID: 28551724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient Perspectives and Preferences Regarding Gout and Gout Management: Impact on Adherence.
    Chung MK; Kim SS; Cheon YH; Hong SJ; Choi HJ; Seo MR; Hwang J; Ahn JK; Lee SH; Min HK; Cha HS; Lee SS; Lee J; Moon KW; Lee CK; Kim HO; Suh YS; Shim SC; Kang SW; Kim J; Choi ST; Song JS; Lee J;
    J Korean Med Sci; 2021 Aug; 36(32):e208. PubMed ID: 34402226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cross-sectional internet-based patient survey of the management strategies for gout.
    Singh JA; Shah N; Edwards NL
    BMC Complement Altern Med; 2016 Mar; 16():90. PubMed ID: 26931313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis.
    Yin R; Li L; Zhang G; Cui Y; Zhang L; Zhang Q; Fu T; Cao H; Li L; Gu Z
    BMJ Open; 2018 Apr; 8(4):e017542. PubMed ID: 29643150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.
    Abhishek A; Jenkins W; La-Crette J; Fernandes G; Doherty M
    Rheumatology (Oxford); 2017 Apr; 56(4):529-533. PubMed ID: 28082620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and clinical characteristics associated with gout flares in an integrated healthcare system.
    Rashid N; Levy GD; Wu YL; Zheng C; Koblick R; Cheetham TC
    Rheumatol Int; 2015 Nov; 35(11):1799-807. PubMed ID: 25991397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better outcomes for patients with gout.
    Day R; Nguyen A; Graham G; Aung E; Coleshill M; Stocker S
    Inflammopharmacology; 2020 Oct; 28(5):1395-1400. PubMed ID: 32095979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence and persistence to urate-lowering therapies in the Irish setting.
    McGowan B; Bennett K; Silke C; Whelan B
    Clin Rheumatol; 2016 Mar; 35(3):715-21. PubMed ID: 25409858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular pre-admission urate-lowering therapy and serum urate testing are associated with a shorter hospital length of stay in people with gout: A nation-wide population-based cohort study.
    Jatuworapruk K; Grainger R; Dalbeth N; Taylor WJ
    Int J Rheum Dis; 2022 Feb; 25(2):154-162. PubMed ID: 34796661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usability testing of Avoiding Diabetes Thru Action Plan Targeting (ADAPT) decision support for integrating care-based counseling of pre-diabetes in an electronic health record.
    Chrimes D; Kitos NR; Kushniruk A; Mann DM
    Int J Med Inform; 2014 Sep; 83(9):636-47. PubMed ID: 24981988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout prevalence and predictors of urate-lowering therapy use: results from a population-based study.
    Pisaniello HL; Lester S; Gonzalez-Chica D; Stocks N; Longo M; Sharplin GR; Dal Grande E; Gill TK; Whittle SL; Hill CL
    Arthritis Res Ther; 2018 Jul; 20(1):143. PubMed ID: 29996922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SToRytelliing to Improve Disease outcomes in Gout (STRIDE-GO) in African American veterans with gout: a trial study protocol.
    Singh JA
    Trials; 2021 Dec; 22(1):879. PubMed ID: 34863255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric evaluation of the Adherence to Refills and Medications Scale (ARMS) in Australians living with gout.
    Schulz M; Day RO; Coleshill MJ; Briggs NE; Aung E
    Clin Rheumatol; 2024 Sep; 43(9):2943-2954. PubMed ID: 39008222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Discontinuation of Urate-Lowering Therapy: A Systematic Review.
    Beslon V; Moreau P; Maruani A; Maisonneuve H; Giraudeau B; Fournier JP
    J Gen Intern Med; 2018 Mar; 33(3):358-366. PubMed ID: 29204974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.